Vidal, Laura

National Health Service · American Society of Clinical Oncology · Royal Marsden NHS Foundation Trust · Boehringer Ingelheim (Germany) · Institute of Cancer Research · Wellcome Sanger Institute · Boehringer Ingelheim (United Kingdom)

1 paper on CoChatORCID 0000-0001-7519-3319

Most cited papers

Verified
Phase I Trial of the Irreversible EGFR and HER2 Kinase Inhibitor BIBW 2992 in Patients With Advanced Solid Tumors
Yap, T. A., Vidal, L., Adam, J., Stephens, P., Spicer, J., Shaw, H., Ang, J., Temple, G., Bell, S., Shahidi, M., et al. (2010) · Journal of Clinical Oncology
Lung Cancer Treatments and MutationsHER2/EGFR in Cancer Research
Cited by 349

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free